Cervical and systemic innate immunity predictors of HIV risk linked to genital herpes acquisition and time from HSV-2 seroconversion. [PDF]
Govender Y+10 more
europepmc +1 more source
Development and characterization of formulations based on combinatorial potential of antivirals against genital herpes. [PDF]
Gaikwad M+8 more
europepmc +1 more source
Antibodies to Crucial Epitopes on HSV-2 Glycoprotein D as a Guide to Dosing an mRNA Genital Herpes Vaccine. [PDF]
Hook LM+9 more
europepmc +1 more source
Comparison of the Accuracy of HSV1 and HSV2 Antibody Tests with PCR in the Diagnosis of Recurrent Genital Herpes. [PDF]
Deng J+4 more
europepmc +1 more source
Treatment of genital herpes using olive leaf extract. [PDF]
Lorzadeh N, Kazemirad Y, Kazemirad N.
europepmc +1 more source
Population-based risk factors and urogenital comorbidities associated with genital herpes: A nationwide study of 4 million women. [PDF]
Sundqvist C+5 more
europepmc +1 more source
Global, Regional, and National Trends Analysis in Incidence of Genital Herpes Among the Population Aged 15-49 Years - Worldwide, 1990-2021. [PDF]
Cao G, Liu J, Liu M, Liang W.
europepmc +1 more source
Lifetime Medical Costs of Genital Herpes in the United States: Estimates From Insurance Claims. [PDF]
Eppink ST, Kumar S, Miele K, Chesson HW.
europepmc +1 more source
Viral Genomic Variation and the Severity of Genital Herpes Simplex Virus-2 Infection as Quantified by Shedding Rate: A Viral Genome-Wide Association Study. [PDF]
Casto AM+8 more
europepmc +1 more source